Abstract
We have combined Invitrogen's Gateway® cloning technology with self‐cleaving purification tags to generate a new system for rapid production of recombinant protein products. To accomplish this, we engineered our previously reported ΔI‐CM cleaving intein to include a Gateway cloning recognition sequence, and demonstrated that the resulting Gateway‐competent intein is unaffected. This intein can therefore be used in several previously reported purification methods, while at the same time being compatible with Gateway cloning. We have incorporated this intein into a set of Gateway vectors, which include self‐cleaving elastin‐like polypeptide (ELP), chitin binding domain (CBD), phasin (polyhydroxybutyrate‐binding), or maltose binding domain (MBD) tags. These vectors were verified by Gateway cloning of TEM‐1 β‐lactamase and Escherichia coli catalase genes, and the expressed target proteins were purified using the four methods encoded on the vectors. The purification methods were unaffected by replacing the ΔI‐CM intein with the Gateway intein. It was observed that some purification methods were more appropriate for each target than others, suggesting utility of this technology for rapid process identification and optimization. The modular design of the Gateway system and intein purification method suggests that any tag and promoter can be trivially added to this system for the development of additional expression vectors. This technology could greatly facilitate process optimization, allowing several targets and methods to be tested in a high‐throughput manner. Biotechnol. Bioeng. 2008;101: 229–240. © 2008 Wiley Periodicals, Inc.